3 not yet recruiting, 1 active not recruiting, 1 completed, 1 unknown. 6 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Not yet recruiting 3, Active not recruiting 1, Completed 1, Unknown 1 |
| Phase 1 | 3 | Not yet recruiting 3 |
Follow HIV -1 Infection: new trials by email Literature Review of HIV -1 Infection trials Research Report on HIV -1 Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Neutralizing Antibodies in Infants Living With HIV to Enhance Their Life Broadly neutralizing antibody (bNAb) ePGT121v1-LS, Saline (0.9% NaCl) - HIV -1 Infection | Phase 1 / Phase 2 | Not yet recruiting | Hospital Universitario 12 de Octubre | 87 | 2027-01-01 | 2026-08-20 |
| Early Neutralizing Antibodies in Infants Living With HIV to Enhance Their Life (2) Broadly neutralizing antibody (bNAb) ePGT121v1-LS, Saline (0.9% NaCl), Broadly neutralizing antibody (bNAb) VRC07-523-LS - HIV -1 Infection | Phase 1 / Phase 2 | Not yet recruiting | Hospital Universitario 12 de Octubre | 73 | 2027-01-01 | 2026-08-20 |
| Combining Latency Reversing Agents to Address the HIV Reservoir Pyrimethamine (PYR), Lenalidomide, Topiramate (drug) - HIV (Human Immunodeficiency Virus), HIV -1 Infection | Phase 1 / Phase 2 | Not yet recruiting | Erasmus Medical Center | 30 | 2026-04-01 | 2026-02-03 |
| HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study TMB-365, TMB-380, Baseline ART - HIV -1 Infection | Phase 2 | Active not recruiting | TaiMed Biologics Inc. | 88 | 2025-12-16 | 2026-08-06 |
| Treatment With Probiotics (Saccharomyces Boulardii) and Its Role in Bacterial Translocation and Immune Reconstitution in VIH Infection. Probiotic., Placebo - HIV -1 Infection | Phase 2 | Unknown | Parc de Salut Mar | 44 | 2012-08-01 | 2016-11-15 |
| Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection PRO 140 (humanized monoclonal antibody to CCR5), Placebo Comparator - HIV -1 Infection, HIV Infections | Phase 2 | Completed | CytoDyn, Inc. | 44 | 2008-03-01 | 2016-01-14 |
Acquired Immunodeficiency Syndrome (1) · HIV Infections (1) · Inflammation (1)
Blood-Borne Infections (2) · Communicable Diseases (2) · Genital Diseases (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Infections (2) · Lentivirus Infections (2) · RNA Virus Infections (2) · Retroviridae Infections (2) · Sexually Transmitted Diseases (2) · Sexually Transmitted Diseases, Viral (2) · Urogenital Diseases (2) · Virus Diseases (2) · HIV Infections (1) · Pathologic Processes (1)
Broadly Neutralizing Antibodies (2) · Sodium Chloride (2) · Lenalidomide (1) · Pharmaceutical Preparations (1) · Probiotics (1) · Pyrimethamine (1) · Topiramate (1) · leronlimab (1)
Hospital Universitario 12 de Octubre (2) · CytoDyn, Inc. (1) · Erasmus Medical Center (1) · Parc de Salut Mar (1) · TaiMed Biologics Inc. (1)
United States (2) · Netherlands (1) · Spain (1)
Casper Rokx, MD PhD (1) · Stephen Morris, MD, PhD (1)